Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 17, 1996

View Archived Issues

New antiplatelet agents described by Thomae

New imaging agents for 19F MRI claimed by Molecular Biosystems

Zeneca reports antiproliferative tyrosine kinase inhibitors

New diuretics reported by Pharmacia & Upjohn

Dual-action compounds claimed by British Biotech

Angiogenesis inhibitors under study at ADIR

More terazosin clinical data reported

SuperGen licenses metalloorganic compounds

Inactivation of SIV by LifeTECH's blood sterilization technology

Cortex notified of broad patent covering calpain inhibitors

Protein Polymer Technologies and Ethicon extend R&D collaboration

Rizatriptan goes head-to-head with sumatriptan in migraine patients

Method for treatment of CPVD available for licensing

Licensees sought for PKD1 gene and mutations

Oscillin and MAbs against it offered for licensing

NIH offers glycoprotein hormone superagonists for licensing

MRC offers Fv1 gene for licensing

Licenses offered for the use of IL-7 in increasing hematopoietic stem cells

Method of producing infectious RSV offered for licensing

CAK1 gene for treatment and diagnosis of cancers available for licensing

Glycine therapy as a potential new approach to schizophrenia Rx

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...